EPA: Dow’s Enlist Duo combining glyphosate and 2,4-D herbicides poses no serious safety concerns

enlist duo

Enlist Duo containing the choline salt of 2,4-D and glyphosate was first registered in 2014 for use in Genetically Engineered (GE) corn and soybean crops in certain states. After granting the registration, the agency discovered that the registrant had made claims of synergy between the ingredients in the herbicide’s formula that had not been shared with EPA at the time of registration. We requested and received a court-ordered remand in January 2016, and then requested and received additional synergy data from the registrant.

EPA’s review of those additional data on synergy confirms EPA’s initial findings of no synergy in the Enlist Duo formulation. The finding of the lack of synergy between the ingredients in Enlist Duo resolves the uncertainty that led to the 2016 remand. These data demonstrate that the combination of 2,4-D choline and glyphosate in Enlist Duo does not show any increased toxicity to plants and is therefore not of concern.

EPA’s protective and conservative human health and ecological risk assessments re-confirmed our 2014 safety findings. The pesticide still meets the safety standard for the public, agricultural workers, and non-target plants and animal species, including species listed as threatened or endangered under the Endangered Species Act.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. Read original post and listen to audio here: EPA Re-affirms Decision on Enlist Duo for GE Crops and Proposes to Amend the Registration

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
ChatGPT-Image-Sep-21-2026-11_54_00-AM
Viewpoint: Activist environmental NGOs are turning from public funding to activist billionaires to support their campaigns. It won’t end well.
Screenshot 2026-08-12 at 1.22
Activists vs. Scientists: Could “Butterfly Effect” fears derail gene-drive research targeting the flesh-eating screwworm?
Screenshot-2026-09-16-at-10.27.33-AM
Viewpoint: SCOTUS poised to address First Amendment tension between mandatory vaccines, children’s health and religious freedom 
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
ChatGPT-Image-Sep-22-2026-11_17_31-AM
The exploding controversy over AI’s built-in survival drive
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.